OneOncology launches OneR, precision oncology research network

By The Science Advisory Board staff writers

October 19, 2020 -- OneOncology has formed a subsidiary named OneOncology Research Network (OneR) as a national nonexclusive clinical trial site management organization to enhance research programs underway at participating community oncology practices.

The organization will provide operational, regulatory and research support services to more efficiently execute multicenter clinical trials. OneR will enhance a practice's ability to increase clinical trial participation by centralizing business functions, regulatory submissions, and clinical trial matching technology.

The OneR platform will increase practices' access to innovative therapies for their patients. The network will also provide trial sponsors with diverse populations of patients. OneR ensures diversity in clinical trial participation including ethnicity, gender, geography, disease status, socioeconomics, and various other dimensions.

OneR will focus on precision oncology to offer clinical trials across tumor types with innovative trial designs like basket and umbrella trials. A basket trial tests how well a new drug works in patients who have different types of cancer that all have the same mutation or biomarker. In umbrella trials, patients with one specific cancer receive treatment based on the molecular profile of their individual cancer.

Flywheel unveils life sciences imaging platform
Research informatics firm Flywheel has introduced an enterprise-wide image management platform geared for the life sciences market.
From lab to clinic: How AI can help
Clinical trials are an important checkpoint in moving therapies from the lab to the clinic, and artificial intelligence (AI) software can help researchers...

Copyright © 2020 scienceboard.net


Conferences
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter